Many accumulating pieces of evidence indicated that SOCS had low expression in various tumors, including lung cancer, gastric cancer, hepatocellular carcinoma, prostate cancer, multiple myeloma, pancreatic cancer, leukemia and lymphoma (18–20). This evidence concerns the gene CISH and pancreatic neoplasm.